SCHEMBL19769279

SCHEMBL19769279

Cc1ccc2c(c1)Oc1cc(OC(=O)C(C)(C)C)ccc1C21OC(=O)c2cc(C(=O)NCCCCCC(=O)N3CCC(C)(CO)CC3)ccc21

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MMP14 P50281 1/20 0.43
▸ KCNH2 Q12809 3/20 0.39
▸ GSTP1 P09211 1/20 0.39
▸ MEN1 O00255 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ALB P02768 1/20 0.37
▸ ITPR3 Q14573 1/20 0.36
▸ P2RY14 Q15391 1/20 0.35
▸ JAK2 O60674 1/20 0.34
▸ CNR1 P21554 2/20 0.34
▸ FTO Q9C0B1 3/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ NR1H2 P55055 2/20 0.34
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19769300 0.95 MMP14 (0.39) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL19769316 0.90 MMP14 (0.42) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL19769317 0.86 MMP14 (0.38) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL19769298 0.83 KCNH2 (0.46) MMP14KCNH2ALDH1A1ALBP2RY14
SCHEMBL6879196 0.82 GSTP1 (0.50) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL13237871 0.78 GSTP1 (0.49) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL22370072 0.77 MMP14 (0.38) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL19601261 0.76 ALDH1A1 (0.41) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL13881238 0.76 GSTP1 (0.46) MMP14KCNH2GSTP1MEN1USP2
SCHEMBL19431854 0.76 GSTP1 (0.47) MMP14KCNH2GSTP1MEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159458-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES AM CHEMICALS LLC (US) 2023-05-25 — — US disclosed
US-20180016232-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES AM CHEMICALS LLC (US) 2018-01-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159458-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES NCL, PAICS, RTCB MMP14 4739/4885KCNH2 4777/4885GSTP1 1314/4885
US-20180016232-A1 SOLID SUPPORTS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTIDE CONJUGATES NCL, PAICS, RTCB MMP14 4739/4885KCNH2 4777/4885GSTP1 1314/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback